Astria to present at upcoming Bradykinin Symposium Astra Therapeutics announced that it will present two posters at the upcoming Bradykinin Symposium...
Vous n'êtes pas connecté
Astria Therapeutics chooses Ypsomed’s YpsoMate as the injection device for STAR-0215 for the treatment of hereditary angioedema Astra Therapeutics announced that it has chosen Ypsomed as its partner for the development of an autoinjector for STAR-0215. John Ruesch, Senior Vice President, Pharmaceutical Sciences and Technical Operations at Astria, said: “With STAR-0215's profile, our goal [...]
Astria to present at upcoming Bradykinin Symposium Astra Therapeutics announced that it will present two posters at the upcoming Bradykinin Symposium...
Astria to present at upcoming Bradykinin Symposium Astra Therapeutics announced that it will present two posters at the upcoming Bradykinin Symposium...
KalVista announces FDA acceptance of New Drug Application for sebetralstat for oral on-demand treatment of hereditary angioedema KalVista...
Pharvaris presents deucrictibant long-term extension data for both the prophylactic and on-demand treatment of HAE at the Bradykinin Symposium 2024...
CAMBRIDGE, Mass. & SALISBURY, England--(BUSINESS WIRE)--Sep. 3, 2024-- KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), today announced that the U.S....
Pharvaris provides business update and expands development program for deucrictibant Pharvaris today announced: The planned initiation of CHAPTER-3,...
BioCryst presents new Orladeyo (berotralstat) data at 7th Bradykinin Symposium BioCryst Pharmaceuticals today announced the presentation of six...
Revive Therapeutics (CSE: RVV) is continuing its efforts into evaluating the uses of Bucillamine, disclosing yesterday an update to its The post...
Updated Date: Mon, 09 Sep 2024 00:00:00 EDT
Updated Date: Mon, 09 Sep 2024 00:00:00 EDT